These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
198 related articles for article (PubMed ID: 33861144)
21. Role of leucine 31 of phospholamban in structural and functional interactions with the Ca2+ pump of cardiac sarcoplasmic reticulum. Chen Z; Stokes DL; Jones LR J Biol Chem; 2005 Mar; 280(11):10530-9. PubMed ID: 15644311 [TBL] [Abstract][Full Text] [Related]
22. A phospholamban-tethered cardiac Ca2+ pump reveals stoichiometry and dynamic interactions between the two proteins. Chen Z Biochem J; 2011 Oct; 439(2):313-9. PubMed ID: 21728996 [TBL] [Abstract][Full Text] [Related]
23. Decoy peptides targeted to protein phosphatase 1 inhibit dephosphorylation of phospholamban in cardiomyocytes. Oh JG; Kim J; Jang SP; Nguen M; Yang DK; Jeong D; Park ZY; Park SG; Hajjar RJ; Park WJ J Mol Cell Cardiol; 2013 Mar; 56():63-71. PubMed ID: 23262438 [TBL] [Abstract][Full Text] [Related]
24. Istaroxime stimulates SERCA2a and accelerates calcium cycling in heart failure by relieving phospholamban inhibition. Ferrandi M; Barassi P; Tadini-Buoninsegni F; Bartolommei G; Molinari I; Tripodi MG; Reina C; Moncelli MR; Bianchi G; Ferrari P Br J Pharmacol; 2013 Aug; 169(8):1849-61. PubMed ID: 23763364 [TBL] [Abstract][Full Text] [Related]
25. Phospholamban pentamerization increases sensitivity and dynamic range of cardiac relaxation. Funk F; Kronenbitter A; Hackert K; Oebbeke M; Klebe G; Barth M; Koch D; Schmitt JP Cardiovasc Res; 2023 Jul; 119(7):1568-1582. PubMed ID: 36869774 [TBL] [Abstract][Full Text] [Related]
26. Phospholamban C-terminal residues are critical determinants of the structure and function of the calcium ATPase regulatory complex. Abrol N; Smolin N; Armanious G; Ceholski DK; Trieber CA; Young HS; Robia SL J Biol Chem; 2014 Sep; 289(37):25855-66. PubMed ID: 25074938 [TBL] [Abstract][Full Text] [Related]
27. Ophiopogonin D Increases SERCA2a Interaction with Phospholamban by Promoting CYP2J3 Upregulation. Wang J; You W; Wang N; Zhou W; Ge Y; Ma Z; Tan H; Wang Y; Gao Y Oxid Med Cell Longev; 2020; 2020():8857906. PubMed ID: 33488937 [TBL] [Abstract][Full Text] [Related]
29. Phospholamban overexpression in rabbit ventricular myocytes does not alter sarcoplasmic reticulum Ca transport. Waggoner JR; Ginsburg KS; Mitton B; Haghighi K; Robbins J; Bers DM; Kranias EG Am J Physiol Heart Circ Physiol; 2009 Mar; 296(3):H698-703. PubMed ID: 19112098 [TBL] [Abstract][Full Text] [Related]
30. Acute inotropic and lusitropic effects of cardiomyopathic R9C mutation of phospholamban. Abrol N; de Tombe PP; Robia SL J Biol Chem; 2015 Mar; 290(11):7130-40. PubMed ID: 25593317 [TBL] [Abstract][Full Text] [Related]
31. Targeting protein-protein interactions for therapeutic discovery via FRET-based high-throughput screening in living cells. Stroik DR; Yuen SL; Janicek KA; Schaaf TM; Li J; Ceholski DK; Hajjar RJ; Cornea RL; Thomas DD Sci Rep; 2018 Aug; 8(1):12560. PubMed ID: 30135432 [TBL] [Abstract][Full Text] [Related]
32. Luteolin Enhances Sarcoplasmic Reticulum Ca2+-ATPase Activity through p38 MAPK Signaling thus Improving Rat Cardiac Function after Ischemia/Reperfusion. Zhu S; Xu T; Luo Y; Zhang Y; Xuan H; Ma Y; Pan D; Li D; Zhu H Cell Physiol Biochem; 2017; 41(3):999-1010. PubMed ID: 28222421 [TBL] [Abstract][Full Text] [Related]
33. Defective Ca(2+) handling proteins regulation during heart failure. Hu ST; Liu GS; Shen YF; Wang YL; Tang Y; Yang YJ Physiol Res; 2011; 60(1):27-37. PubMed ID: 20945956 [TBL] [Abstract][Full Text] [Related]
34. Intermolecular conformational coupling and free energy exchange enhance the catalytic efficiency of cardiac muscle SERCA2a following the relief of phospholamban inhibition. Mahaney JE; Albers RW; Waggoner JR; Kutchai HC; Froehlich JP Biochemistry; 2005 May; 44(21):7713-24. PubMed ID: 15909986 [TBL] [Abstract][Full Text] [Related]
35. Tumor necrosis factor alpha protects heart cultures against hypoxic damage via activation of PKA and phospholamban to prevent calcium overload. El-Ani D; Philipchik I; Stav H; Levi M; Zerbib J; Shainberg A Can J Physiol Pharmacol; 2014 Nov; 92(11):917-25. PubMed ID: 25349921 [TBL] [Abstract][Full Text] [Related]
36. Increased inhibition of SERCA2 by phospholamban in the type I diabetic heart. Vasanji Z; Dhalla NS; Netticadan T Mol Cell Biochem; 2004 Jun; 261(1-2):245-9. PubMed ID: 15362510 [TBL] [Abstract][Full Text] [Related]
37. Interaction between increased SERCA2a activity and beta -adrenoceptor stimulation in adult rabbit myocytes. Chaudhri B; Del Monte F; Hajjar RJ; Harding SE Am J Physiol Heart Circ Physiol; 2002 Dec; 283(6):H2450-7. PubMed ID: 12388307 [TBL] [Abstract][Full Text] [Related]
38. Close proximity between residue 30 of phospholamban and cysteine 318 of the cardiac Ca2+ pump revealed by intermolecular thiol cross-linking. Jones LR; Cornea RL; Chen Z J Biol Chem; 2002 Aug; 277(31):28319-29. PubMed ID: 12015326 [TBL] [Abstract][Full Text] [Related]
39. Phospholamban ablation by RNA interference increases Ca2+ uptake into rat cardiac myocyte sarcoplasmic reticulum. Watanabe A; Arai M; Yamazaki M; Koitabashi N; Wuytack F; Kurabayashi M J Mol Cell Cardiol; 2004 Sep; 37(3):691-8. PubMed ID: 15350842 [TBL] [Abstract][Full Text] [Related]
40. Phospholamban mutants compete with wild type for SERCA binding in living cells. Gruber SJ; Haydon S; Thomas DD Biochem Biophys Res Commun; 2012 Apr; 420(2):236-40. PubMed ID: 22405774 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]